Holen Sie sich die Stockscreener-App
13.28
1.70%
-0.23
Finanzdaten der Neuropace Inc-Aktie (NPCE)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
3.43%
22.83
|
22.07 | 26.59 | 27.35 | 23.52 |
| Cost Of Revenue |
2.49%
3.92
|
4.02 | 6.01 | 6.186 | 5.388 |
| Gross Profit |
4.75%
18.91
|
18.05 | 20.58 | 21.17 | 18.13 |
| Operating Expenses |
1.83%
24.05
|
23.62 | 22.34 | 23.77 | 24.96 |
| Operating Income/Loss |
7.63%
-5.143
|
-5.568 | -1.767 | -2.60 | -6.824 |
| Income/Loss From Continuing Operations After Tax |
-6.20
|
- | -2.729 | -3.496 | -8.651 |
| Income/Loss From Discontinued Operations, Net Of Tax |
-
|
- | - | - | - |
| Net Income/Loss |
7.31%
-6.20
|
-6.689 | -2.729 | -3.496 | -8.651 |
| Basic Average Shares |
1.15%
34.10
|
33.72 | 0.2235 | 33.13 | 32.86 |
| Diluted Average Shares |
1.15%
34.10
|
33.72 | 0.2235 | 33.13 | 32.86 |
| Basic Earnings Per Share |
10.00%
-0.18
|
-0.20 | -0.08 | -0.11 | -0.26 |
| Diluted Earnings Per Share |
10.00%
-0.18
|
-0.20 | -0.08 | -0.11 | -0.26 |
| Common Stock Dividends |
-
|
- | - | - | - |
7.68%
6.41%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):